Translational Development Acquisition Corp. Ordinary Shares (TDAC) — Cash Flow-to-Debt Ratio
Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a Cash Flow-to-Debt Ratio of -0.19x as of September 2025, meaning its operating cash flow of $-1.24 Million could theoretically repay 0% of its total liabilities ($6.46 Million) in one year. See Translational Development Acquisition Co (TDAC) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Translational Development Acquisition Corp. Ordinary Shares Cash Flow-to-Debt Ratio (2022–2024)
Historical debt coverage capacity for Translational Development Acquisition Corp. Ordinary Shares across 3 annual periods. Also explore Translational Development Acquisition Co net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Translational Development Acquisition Corp. Ordinary Shares (2022–2024)
Year-by-year debt coverage analysis for Translational Development Acquisition Corp. Ordinary Shares. For market capitalisation and broader financial context, see how much is Translational Development Acquisition Co worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.14x | $-851.45K | $6.25 Million | ▼ -33948.4% |
| 2023 | 0.00x | $-204.00 | $509.68K | ▲ +99.8% |
| 2022 | -0.21x | $-97.16K | $459.34K | — |